Evolent Health, Inc. (EVH) Financials

EVH Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.9 billion 1.5 billion
Dec. 31, 2025 1.9 billion 1.5 billion
Sept. 30, 2025 2.5 billion 1.6 billion
June 30, 2025 2.5 billion 1.6 billion

EVH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -7.4 million ?
Dec. 31, 2025 41.0 million -2.4 million
Sept. 30, 2025 6.9 million 14.7 million
June 30, 2025 -39.1 million 11.6 million

EVH Net Income

No data available :(

EVH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 166.0 million 973.5 million 3.2 million
Dec. 31, 2025 151.9 million 970.5 million 19.2 million
Sept. 30, 2025 116.7 million 1.1 billion 22.4 million
June 30, 2025 151.0 million 648.5 million 32.6 million

EVH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 111.9 million
Dec. 31, 2025 114.2 million
Sept. 30, 2025 114.1 million
June 30, 2025 115.9 million

EVH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 6.4 million - 72.1 million -
Dec. 31, 2025 7.8 million - 61.9 million -
Sept. 30, 2025 9.0 million 5600 75.2 million -
June 30, 2025 8.8 million - 74.1 million -

EVH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 496.2 million 434.3 million
Dec. 31, 2025 468.7 million 416.5 million
Sept. 30, 2025 479.5 million 403.7 million
June 30, 2025 444.3 million 367.4 million

EVH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

EVH

Price: $5.85

52 week price:
2.10
12.07

Payout Ratio Range:
-300.44%
317.48%

Earnings Per Share: -4.68 USD

Exchange: NYQ

Sector: Healthcare

Industry: Health Information Services

Country: United States

Volume: 198391

Ebitda: -6.2 million

Market Capitalization: 642.3 million

Links: